These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6172132)

  • 21. Genetic regulation of hypergammaglobulinaemia and the correlation to autoimmune traits in (NZB X NZW) F1 hybrid.
    Hirose S; Sekigawa I; Ozaki S; Sato H; Shirai T
    Clin Exp Immunol; 1984 Dec; 58(3):694-702. PubMed ID: 6334582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful treatment of autoimmunity in (NZB X NZW)F1 mice with cyclosporin and (Nva2)-cyclosporin: II. Reduction of glomerulonephritis.
    Gunn HC; Ryffel B
    Clin Exp Immunol; 1986 May; 64(2):234-42. PubMed ID: 3742874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elimination of CD4(+)CD25(+) T cell accelerates the development of glomerulonephritis during the preactive phase in autoimmune-prone female NZB x NZW F mice.
    Hayashi T; Hasegawa K; Adachi C
    Int J Exp Pathol; 2005 Oct; 86(5):289-96. PubMed ID: 16191101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro production of anti-histone antibodies by spleen cells from young autoantibody negative NZB/NZW mice.
    O'Dell JR; Kotzin BL
    J Immunol; 1985 Aug; 135(2):1101-7. PubMed ID: 3874228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulated autoantibody response and increased longevity in NZB/NZW mice treated with cyclophosphamide and tilorone.
    Walker SE; Anver MR
    Clin Exp Immunol; 1978 Sep; 33(3):453-62. PubMed ID: 737897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of the anti-estrogen, Nafoxidine, on NZB/W autoimmune disease.
    Duvic M; Steinberg AD; Klassen LW
    Arthritis Rheum; 1978 May; 21(4):414-7. PubMed ID: 306824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of induced chronic viral infections on the immunologic diseases of New Zealand mice.
    Tonietti G; Oldstone MB; Dixon FJ
    J Exp Med; 1970 Jul; 132(1):89-109. PubMed ID: 4323748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment with high doses of anti-IgM prevents, but with lower doses accelerates autoimmune disease in (NZW x BXSB)F1 hybrid mice.
    Cerny A; Starobinski M; Hügin AW; Sutter S; Zinkernagel RM; Izui S
    J Immunol; 1987 Jun; 138(12):4222-8. PubMed ID: 3495583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Male New Zealand Black/KN mice: a novel model for autoimmune-induced permanent alopecia?
    Hiroi A; Ito T; Seo N; Uede K; Yoshimasu T; Ito M; Nakamura K; Ito N; Paus R; Furukawa F
    Br J Dermatol; 2006 Aug; 155(2):437-45. PubMed ID: 16882186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrinsic B cell defects in NZB and NZW mice contribute to systemic lupus erythematosus in (NZB x NZW)F1 mice.
    Reininger L; Winkler TH; Kalberer CP; Jourdan M; Melchers F; Rolink AG
    J Exp Med; 1996 Sep; 184(3):853-61. PubMed ID: 9064345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tolerance defects in New Zealand Black and New Zealand Black X New Zealand White F1 mice.
    McCoy KL; Kendrick L; Chused TM
    J Immunol; 1986 Feb; 136(4):1217-22. PubMed ID: 3944456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlations of autoimmunity with H-2 and T cell receptor beta chain genotypes in (NZB X NZW) F2 mice.
    Noonan DJ; McConahey PJ; Cardenas GJ
    Eur J Immunol; 1990 May; 20(5):1105-10. PubMed ID: 1972678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancing effect of H-2-linked NZW gene(s) on the autoimmune traits of (NZB X NZW)F1 mice.
    Hirose S; Nagasawa R; Sekikawa I; Hamaoki M; Ishida Y; Sato H; Shirai T
    J Exp Med; 1983 Jul; 158(1):228-33. PubMed ID: 6864161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic contributions to lupus-like disease in NZB/NZW mice.
    Kotzin BL; Palmer E
    Am J Med; 1988 Dec; 85(6A):29-31. PubMed ID: 3264457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of NZB/NZW mice with total lymphoid irradiation: long-lasting suppression of disease without generalized immune suppression.
    Kotzin BL; Arndt R; Okada S; Ward R; Thach AB; Strober S
    J Immunol; 1986 May; 136(9):3259-65. PubMed ID: 2937842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful treatment of autoimmune disease in (NZB/NZW)F1 female mice by using fractionated total lymphoid irradiation.
    Slavin S
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5274-6. PubMed ID: 291944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Y chromosome from autoimmune BXSB/MpJ mice induces a lupus-like syndrome in (NZW x C57BL/6)F1 male mice, but not in C57BL/6 male mice.
    Izui S; Higaki M; Morrow D; Merino R
    Eur J Immunol; 1988 Jun; 18(6):911-5. PubMed ID: 3260184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of inducers of endogenous interferon on the course of an autoimmune process in F1 inbred NZB/NZW mice].
    Nasonova VA; Balabanova RM; Pleskovskaia GN; Venikova MS; Poverennyĭ AM; Podgorodnichenko VK; Popova GA
    Vopr Virusol; 1990; 35(5):408-11. PubMed ID: 2267785
    [No Abstract]   [Full Text] [Related]  

  • 39. Prostaglandin E1 treatment of NZB/NZW F1 hybrid mice. II. Prevention of glomerulonephritis.
    Zurier RB; Damjanov I; Sayadoff DM; Rothfield NF
    Arthritis Rheum; 1977; 20(8):1449-56. PubMed ID: 144506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of major histocompatibility complex on autoimmune disease of H-2-congenic New Zealand mice.
    Hirose S; Kinoshita K; Nozawa S; Nishimura H; Shirai T
    Int Immunol; 1990; 2(11):1091-5. PubMed ID: 2083229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.